<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nucleophosmin (also known as NPM, B23, NO38) is a nucleolar protein directly implicated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathogenesis, as the NPM1 gene is found mutated and rearranged in a number of <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, the region of chromosome 5 to which NPM1 maps is deleted in a proportion of de novo human <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and loss of chromosome 5 is extremely frequent in <z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">therapy-related MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>NPM is a multifunctional protein, and its role in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> is controversial as NPM has been attributed with both oncogenic and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressive functions </plain></SENT>
<SENT sid="3" pm="."><plain>To study the function of Npm in vivo, we generated a hypomorphic Npm1 mutant series (Npm1+/- &lt; Npm1(hy/hy) &lt; Npm1-/-) in mouse </plain></SENT>
<SENT sid="4" pm="."><plain>Here we report that Npm is essential for embryonic development and the maintenance of genomic stability </plain></SENT>
<SENT sid="5" pm="."><plain>Npm1-/- and Npm1(hy/hy) mutants have aberrant organogenesis and die between embryonic day E11.5 and E16.5 owing to severe <z:hpo ids='HP_0001903'>anaemia</z:hpo> resulting from defects in primitive haematopoiesis </plain></SENT>
<SENT sid="6" pm="."><plain>We show that Npm1 inactivation leads to unrestricted centrosome duplication and genomic instability </plain></SENT>
<SENT sid="7" pm="."><plain>We demonstrate that Npm is haploinsufficient in the control of genetic stability and that Npm1 heterozygosity accelerates <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> both in vitro and in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>Notably, Npm1+/- mice develop a haematological syndrome with features of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Our findings uncover an essential developmental role for Npm and implicate its functional loss in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> pathogenesis </plain></SENT>
</text></document>